BioMed Research International

Novel Developments in Acute Kidney Injury


Status
Published

1Geisel School of Medicine at Dartmouth, Lebanon, USA

2Baylor Heart and Vascular Institute, Dallas, USA

3Vanderbilt University, Nashville, USA


Novel Developments in Acute Kidney Injury

Description

Acute kidney injury (AKI) develops routinely among hospitalized patients, perioperatively, as well as in the community. Although recent clinical trials have made great strides towards understanding the pathophysiology of acute kidney injury and therapeutic agents, effective prevention and treatment of acute kidney injury remain uncertain at the front lines of healthcare.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the pathophysiology, early detection, treatment, and prevention of acute kidney injury. We are particularly interested in novel meta-analyses of acute kidney injury treatment, prevention, and detection; advances in novel acute kidney injury pathophysiology; and new insights into acute kidney injury and clinical outcomes.

Potential topics include but are not limited to the following:

  • Meta-analyses
  • Advances in early detection and biomarkers
  • Latest technologies for prevention and treatment
  • Clinical evaluation of modifiable risk factors and devices to prevent or minimize acute kidney injury
  • Epidemiological studies
  • Community-acquired acute kidney injury
  • Recent advances in acute kidney injury prevention
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.